08/12/2024 | Press release | Distributed by Public on 08/12/2024 06:37
IN8bio Solidifies Position as a Clinical Leader of Gamma Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for[...]
